JLE

European Journal of Dermatology

MENU

Intravenous immunoglobulins for delayed wound healing associated with toxic epidermal necrolysis Volume 29, numéro 2, March-April 2019

Illustrations


  • Figure 1
Auteurs
1 Department of Adult and Pediatric Dermatology,
2 Department of Intensive Care and Burn Centre, Bordeaux University Hospitals, France

The use of intravenous immunoglobulins (IVIg) as a treatment for immune system disorders is well known, but currently debated for the acute stage of toxic epidermal necrolysis (TEN) [1-4]. Recently, the clinical benefit of IVIg, at substitutive doses, on skin damage in Netherton's syndrome was reported [5]. We report here the efficacy of IVIg in a patient who presented with major delayed wound healing following TEN.A 60-year-old woman was hospitalised at a burns centre for TEN induced by carbamazepine. [...]